Abstract
There is evidence of possible beneficial effects of probiotic products in non-alcoholic fatty liver disease (NAFLD). Here the effects of probiotic yogurt consumption on obesity values, fasting insulin, insulin resistance, and serum leptin and adiponectin levels in NAFLD patients were investigated by a randomized double-blind controlled clinical trial. Seventy-two subjects, aged between 23 and 63 years, were divided into two groups. Subjects consumed either 300 g/day of probiotic yogurt or 300 g/day of conventional yogurt for 8 weeks. Probiotic yogurt consumption resulted in a significant reduction in weight, body mass index, and serum levels of fasting insulin as compared with that in the control group. No significant changes were observed in waist circumference, homeostasis model assessment insulin resistance, serum leptin, adiponectin, and leptin to adiponectin ratio in both groups. Our study suggests that probiotic yogurt consumption improved body mass index and insulin levels and may be applicable in reducing risk factors of NAFLD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.